X

Future Oncology

Future Oncology
An update of venetoclax and obinutuzumab in chronic lymphocytic leukemia.

In the last decade, treatment of chronic lymphocytic leukemia has shifted away from chemoimmunotherapy toward targeted novel agents such as small molecule inhibitors and antibodies. 

Future Oncology
10/16/2020
Evolving use of real-world evidence in the regulatory process: a focus on immuno-oncology treatment and outcomes.

In this article, current literature on the use of RWE for regulatory submissions is reviewed, with a focus on novel anticancer immunotherapies, and discussion on the utility and...

Future Oncology
10/19/2020
Physician treatment of metastatic triple-negative breast cancer in the immuno-oncology era: a discrete choice experiment.

To better understand the influence of treatment of triple-negative mBC, a discrete choice experiment was designed to examine the influence of patient age, disease severity...

Future Oncology
09/21/2020
Subscribe to Future Oncology

source list reference

#7d60d9
#2694a4
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#42fc9a
#cc529a
#c59445
#c8cc0c
#e8085a
#97d1a0
#b61f77
#a153ac
#e7f6e3
#9a8c2c
#a9c507
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#575662
#49cde9
#c20fce
#d95d39